I think Trding posted it here some time ago, but the largest BO ever was 17x (1,700%) premium. Your points match my opinion as to why CytoDyn has been bought yet. I don’t think a BP can justify to their BOD and shareholders to offer a fair value based on all the massive sizes of multiple indications and CytoDyn can’t accept pennies for dollars. IMO we need the share price to increase before too many offers come in. Should be an interesting next few months and hopefully year/s.

BTW, thank you for updating the iHub page. I don’t go there much, but know some new investors will and your efforts are appreciated.